Ozanimod (RPC1063) is a specific and potent small molecule modulator of S1PR1 and S1P receptor 5 (S1PR5) that is therapeutically beneficial in clinical trials in relapsing MS [12–14] and ulcerative colitis [15]. Here, S1PR1 is linked to ulcerative colitis.